BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38193230)

  • 21. Robot-assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer: Evolution of the Technique.
    Stepanian S; Patel M; Porter J
    Eur Urol; 2016 Oct; 70(4):661-667. PubMed ID: 27068395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paratesticular rhabdomyosarcoma-Impact of locoregional approach on patient outcome: A report from the European paediatric Soft tissue sarcoma Study Group (EpSSG).
    Rogers TN; De Corti F; Burrieza GG; Guérin F; Terwisscha van Scheltinga S; Smeulders N; Craigie R; Jenney M; Kelsey A; Zanetti I; Coppadoro B; De Salvo GL; Bisogno G; Martelli H
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28479. PubMed ID: 32573979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment strategies and outcomes for spinal rhabdomyosarcoma: A series of 11 cases in a single center and review of the literature.
    Wang T; Gao X; Yang J; Guo W; Wu Z; Tang L; Cao S; Cai X; Liu T; Jia Q; Xiao J
    Clin Neurol Neurosurg; 2020 May; 192():105729. PubMed ID: 32058205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stage I seminoma: Outcome of different treatment modalities and changes in patterns of care. A single institution experience.
    Mahmoud Sayed M; Nasr AM; Saad Eldin IM; Abdelazim YA
    Arch Ital Urol Androl; 2023 Feb; 95(1):11057. PubMed ID: 36924377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Factors and Treatment Outcomes of Adult Patients With Rhabdomyosarcoma After Multimodality Treatment.
    Liu YT; Wang CW; Hong RL; Kuo SH
    Anticancer Res; 2019 Mar; 39(3):1355-1364. PubMed ID: 30842169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.
    Fléchon A; Tavernier E; Boyle H; Meeus P; Rivoire M; Droz JP
    BJU Int; 2010 Sep; 106(6):779-85. PubMed ID: 20089110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rhabdomyosarcoma: the experience of the pediatric unit of Kasr El-Aini Center of Radiation Oncology and Nuclear Medicine (NEMROCK) (from January 1992 to January 2001).
    Abd El-Aal HH; Habib EE; Mishrif MM
    J Egypt Natl Canc Inst; 2006 Mar; 18(1):51-60. PubMed ID: 17237856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternative approaches to retroperitoneal lymph node dissection for paratesticular rhabdomyosarcoma.
    Mansfield SA; Murphy AJ; Talbot L; Prajapati H; Maller V; Pappo A; Singhal S; Krasin MJ; Davidoff AM; Abdelhafeez A
    J Pediatr Surg; 2020 Dec; 55(12):2677-2681. PubMed ID: 32345499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term results of three-dimensional conformal radiation therapy for patients with rhabdomyosarcoma.
    Wolden SL; La TH; LaQuaglia MP; Meyers PA; Kraus DH; Wexler LH
    Cancer; 2003 Jan; 97(1):179-85. PubMed ID: 12491519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors and surgical treatment guidelines for children with rhabdomyosarcoma of the perineum or anus: a report of Intergroup Rhabdomyosarcoma Studies I through IV, 1972 through 1997.
    Blakely ML; Andrassy RJ; Raney RB; Anderson JR; Wiener ES; Rodeberg DA; Paidas CN; Lobe TE; Crist WM;
    J Pediatr Surg; 2003 Mar; 38(3):347-53. PubMed ID: 12632347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: results of the Malignant Mesenchymal Tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology.
    Stewart RJ; Martelli H; Oberlin O; Rey A; Bouvet N; Spicer RD; Godzinski J; Stevens MC;
    J Clin Oncol; 2003 Mar; 21(5):793-8. PubMed ID: 12610176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Para-aortic irradiation only appears to be adequate treatment for patients with Stage I seminoma of the testis.
    Sultanem K; Souhami L; Benk V; Bahary JP; Roman T; Shenouda G; Freeman C
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):455-9. PubMed ID: 9457835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative Effectiveness of Risk-adapted Surveillance vs Retroperitoneal Lymph Node Dissection in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: A Retrospective Follow-up Study of 81 Patients.
    Fan G; Zhang L; Yi L; Jiang ZQ; Ke Y; Wang XS; Xiong YY; Han WQ; Zhou X; Liu C; Yu X
    Asian Pac J Cancer Prev; 2015; 16(8):3267-72. PubMed ID: 25921130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paratesticular rhabdomyosarcoma in children.
    Cromie WJ; Raney RB; Duckett JW
    J Urol; 1979 Jul; 122(1):80-2. PubMed ID: 458995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological features and survival of testicular tumours in a Southeast Asian university hospital: a ten-year review.
    Tan GH; Azrif M; Shamsul AS; Ho CC; Praveen S; Goh EH; Bahadzor B; Ismail F; Zulkifli MZ
    Asian Pac J Cancer Prev; 2011; 12(10):2727-30. PubMed ID: 22320982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of retroperitoneal lymphadenectomy in localized paratesticular rhabdomyosarcoma.
    Goldfarb B; Khoury AE; Greenberg ML; Churchill BM; Smith CR; McLorie GA
    J Urol; 1994 Aug; 152(2 Pt 2):785-7. PubMed ID: 8022014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome and patterns of failure in testicular lymphoma: a multicenter Rare Cancer Network study.
    Zouhair A; Weber D; Belkacémi Y; Ketterer N; Dietrich PY; Villà S; Scandolaro L; Bieri S; Studer G; Delacretaz F; Girardet C; Mirimanoff RO; Ozsahin M;
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):652-6. PubMed ID: 11849786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Durability of oncological outcomes of combination chemotherapy as a monotherapy for a select patient subset with non-metastatic non-alveolar bladder/prostate rhabdomyosarcoma.
    Abdelhalim A; Atwa AM; Helmy TE; Dawaba ME; Elashry R; Hafez AT
    J Pediatr Urol; 2021 Aug; 17(4):535.e1-535.e8. PubMed ID: 34092511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes Following Proton Therapy for Group III Pelvic Rhabdomyosarcoma.
    Indelicato DJ; Rotondo RL; Krasin MJ; Mailhot Vega RB; Uezono H; Bradfield S; Agarwal V; Morris CG; Bradley JA
    Int J Radiat Oncol Biol Phys; 2020 Apr; 106(5):968-976. PubMed ID: 31987977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.